Lapsi Health, a Netherlands-based developer of audio-driven med tech and remote healthcare tools, has raised $3.7 million in what is being billed as an oversubscribed seed round.
The round is led by Modi Ventures, a Texas-based family office. It also includes a couple of Lapsi's pre-seed investors, Vendash and Bolwork, in addition to participation by BeKey, an Israeli-Ukrainian startup hub focused on software development.
Founded in 2022, Lapsi Health aims to enhance remote healthcare provision by allowing clinicians to use a catalogue of clinical stethoscope ausculatory sounds - for example breathing sounds in the lungs - to screen, monitor and treat patients away from the clinic.
The startup's database of stethoscope audio data would be used to build medical devices, telemedicine platforms, remote monitoring systems and digital therapeutics. Now armed with $3.7 million in seed funds, Lapsi Health is ramping up activities in the US in preparation for an FDA regulatory submission.
Lapsi Health was successful in the EU-funded EUREKA Eurostars startup contest in the middle of last year, and with that accolade collected €1.1 million in prize funding.
This time last year the startup was preparing to announce its €700,000 pre-seed raise. Before 2022 was out the team had managed to launch "four generations of prototypes and two native applications."
Jhonatan Bringas Dimitriades, CEO of Lapsi Health, said: "We have been able to validate our technology and showcase it in several venues worldwide and to several medical leaders. This helped us to secure the next step in the funding for our company, now with the goal of bringing our technology to the market during 2023.”
Diana van Stijn, Lapsi chief medical officer and co-founder, added: "Data driven decisions are the next step to improving healthcare, patient empowerment, clinical intelligence and to make clinical research more democratized. These are the ideals that inspired us to create Lapsi Health."